Pivotal Study for Validation of Philips Dx (PDx)

NCT02529137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-05-28

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to show safety and effectiveness of the PDx for In Vitro Diagnostic (IVD) use as an aid to the pathologist to view, review and diagnose digital images of surgical pathology slides.

Conditions

  • Pathologic Processes

Sponsors & Collaborators

  • Philips Digital & Computational Pathology

    lead INDUSTRY

Principal Investigators

  • Mischa Nelis · Philips DPS

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-05-31
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02529137 on ClinicalTrials.gov